Method of treating parkinson's syndrome
US4916151A · kind A · utility
14Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 1989 |
| Grant date | Apr 10, 1990 |
| Priority date | — |
| Expiry date | Mar 10, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel nonaromatic fluoroallylamines are potent MAO inhibitors and at low dose selectively inhibit MAO-B. They are useful in the treatment of depression and co-administration with L-dopa and decarboxylase inhibitors, in the treatment of Parkinsonism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.